Research output per year
Research output per year
Research output
Search results
-
2023
A MACHINE LEARNING MODEL FOR IDENTIFYING IMPORTANT CLINICAL VARIABLES AND PREDICTING ONE-YEAR TREATMENT RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS PERFORMING AN INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCH
Prenga, N., Nabi, H., Krogh, N. S., Akkoc, A., Hetland, M. L. & Glintborg, B., 2023, p. Annals of the rheumatic diseases, vol. 82 suppl. 1, page 494.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
DOES A MANDATORY SWITCH FROM ORIGINATOR ADALIMUMAB TO BIOSIMILAR GP2017 OR SB5 LEAD TO INCREASED HOSPITAL COSTS? A DANBIO STUDY OF >1,300 PATIENTS WITH INFLAMMATORY ARTHRITIS
Nabi, H., Ibsen, R., Ibsen, M., Kjellberg, J., Hetland, M. L. & Glintborg, B., 2023, p. Annals of the rheumatic diseases, vol. 82, suppl. 1, page 441.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
2022
Biosimilar-to-Biosimilar Switching in Routine Care – Results on >1,600 Patients with Inflammatory Arthritis in the DANBIO Registry
Nabi, H., Hendricks, O., Jensen, D. V., Loft, A. G., Pedersen, J., Just, S. A., Danebod, K., Munk, H. L., Kristensen, S., Manilo, N., Colic, A., Linauskas, A., Thygesen, P. H., Christensen, L., Kalisz, M. H., Lomborg, N., Chrysidis, S., Raun, J. L., Andersen, M. & Mehnert, F. & 3 others, , 2022, p. Arthritis & Reumatology Vol. 74, number S9, p. 2209.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review